Reviva Pharmaceuticals Holdings, Inc. SEC filings RVPH

Reviva Pharmaceuticals Holdings, Inc. has 413 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Nov 4, 2025 Dec 31, 2024
10-K Annual report Apr 3, 2025 Dec 31, 2024
ARS Annual report to shareholders Oct 28, 2024 Dec 31, 2023
10-K Annual report Apr 15, 2024 Dec 31, 2023
ARS Annual report to shareholders Oct 4, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K/A Amended annual report May 7, 2021 Dec 31, 2020
10-K/A Amended annual report Mar 24, 2021 Dec 31, 2020
10-K Annual report Mar 22, 2021 Dec 31, 2020
10-K Annual report May 4, 2020 Feb 29, 2020
10-K Annual report May 22, 2019 Feb 28, 2019

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RVPH (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cupertino, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1742927
Former names
Tenzing Acquisition Corp. (until Dec 14, 2020)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.